Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study

Pierre Sesques
Yassine Al Tabaa
Fabrice Jardin
Sylvain Choquet
Jacques-Olivier Bay
  • Fonction : Auteur
  • PersonId : 1069255
François-Xavier Gros
Olivier Casasnovas
Catherine Thieblemont
Laure Ricard
Caroline Régny
  • Fonction : Auteur
  • PersonId : 1011519

Dates et versions

hal-04344759 , version 1 (14-12-2023)

Identifiants

Citer

Pierre Sesques, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loic Ysebaert, et al.. Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study. 65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.893, ⟨10.1182/blood-2023-177703⟩. ⟨hal-04344759⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More